1,447 research outputs found

    Paru : "Histoire d' un projet : de la demande à l' usage" / Jean-Jacques Terrin, Loïc Couton, Editions InFolio, juin 2019

    No full text
    "Histoire d' un projet : de la demande à l' usage" / Jean-Jacques Terrin, Loïc Couton, Editions InFolio, juin 2019, 1 Vol. (240 p.), ISBN 9782884748414 Résumé éditeur : Ce livre décrit le processus d’élaboration du Hangar 108, siège social de la Métropole Rouen Normandie, par l’architecte Jacques Ferrier, l’ingénieur Jean-Marc Weil et toute l’équipe de conception qui les assiste. Depuis sa programmation initiale jusqu’à sa réception et l’amorce de son usage, il révèle les différentes co..

    DIARRHEA IN EARLY LIFE: PROGRESS IN DIAGNOSIS AND CONTROL OF DISEASE

    No full text
    Diarrheal diseases occurring in early life (< 3 years) are an heterogeneous group of abnormalities including gastrointestinal infections, food hypersensitivity and allergy, immune dysregulation, and primary abnormalities of the enterocyte. Diarrhea is a leading cause of illness and death in children younger than 3 years worldwide, causing 1-3 million deaths every year. Despite defining etiology of diarrhea is critical to decide therapy and prevention strategy, the overall prevalence of early onset diarrhea was not clearly defined because of the large spectrum of etiologies and difficulties in patient selection. From a clinical point of view, diarrhea needs to be classified taking into account certain characteristics such as trends over time (acute or chronic, using a limit of 4 week to separate the two conditions) and the characteristics of the feces. Acute diarrheal diseases occurring in early life, usually due to infectious agent or food allergy, were burdened by an increased mobility and mortality, whereas chronic evolution of early onset diarrhea frequently suggests a congenital disorder determined by genetic defects. Using this classification a pediatrician can decide upon diagnosis and therapy more rationally. However, acute diarrhea may be also a symptom of the onset of chronic organic or functional disease. In younger children acute diarrhea will lead to severe dehydration. Fluid loss and dehydration are the cause of death in nearly all children with acute diarrhea. Over 3 decades ago, the discovery of mechanisms of intestinal electrolytes transport, which was the basis for the development of oral treatment of dehydration, was hailed as the most important medical advance of the 20th century. Complications can be prevented by the early and adequate oral administration of a rehydration solution, by normal food for the child's age, and through induction of benefical intestinal microbiota composition. The evidence-based guidelines of the ESPGHAN and Cochrane analyses, based also on studies reported in this manuscript, indicate zinc and probiotics as useful therapeutic aids for children younger than 3 years with acute diarrhea. Chronic diarrhea in early life includes a group of rare chronic enteropathies characterized by a heterogeneous etiology, which in most cases is related to an identified or to an as yet unidentified genetic defect, generally inherited as an autosomal recessive trait. These congenital diarrheal disorders (CDD, OMIM 251850) represent one of the most challenging clinical conditions for pediatric gastroenterologists because of the severity of the clinical picture and the broad range of conditions in its differential diagnosis. Early in life, patients affected by CDD usually present with severe diarrhea that within a few hours leads to a life-threatening condition secondary to massive dehydration and metabolic acidosis. Consequently, children affected by CDD require a prompt diagnosis and assistance. Clinical manifestations are variable from severe conditions leading to intestinal failure, to milder forms with subtle clinical signs that may remain undiagnosed until adulthood, when patients have just developed irreversible complications. Intestinal failure may lead to the necessity of total parenteral nutrition with further complications for the health of the subject affected by these disorders. The number of conditions included within the CDD group has gradually increased over the years. Now it is clear that CDD depend on defects in the structure and function of absorptive, enteroendocrine or inflammatory cells of the gut, determined by mutations in genes expressed throughout the gastrointestinal tract involving different segments and different cells. Therefore, we have proposed that CDD could be classified into 4 groups: (i) Absorption and transport of nutrients and electrolytes; (ii) Enterocyte differentiation and polarization; (iii) Enteroendocrine cell differentiation; and (iv) Modulation of the intestinal immune response. In recent years, many new genes have been identified. Such molecular techniques as positional candidate genes and genome-wide linkage analysis have clarified the role of these genes in the physiology of the gastrointestinal tract. Understanding the function of this genes may open new diagnostic and therapeutic perspectives for chronic and acute forms of early onset diarrhea. The early postnatal period represents a critical window during which the evolving intestine is programmed by intrinsic (genetic programming) and extrinsic factors (microbe, nutrition, drugs). Intestinal content may modify pretranslational and post-translational gene expression. These ‘‘epigenetic’’ mechanisms are involved in the development of gut enzymes, hormones, transporters, and immunity. Occurrence of diarrheal diseases and related treatments, during this temporarily window, may influence the entire body health status in the short and long-term period. In this scenario, accurate identification and adequate control of diarrheal disorders occurring in early life are crucial for reducing morbidity and mortality. Finally, advances made in the pathophysiology of chronic early onset diarrheal disorders could contributed to a better understanding the mechanisms also of the more common acute diarrheal diseases and to identify novel strategy for disease control. Starting from these considerations, we elaborate selected items focusing on the new diagnostic, therapeutic and preventive strategies for diarrheal diseases occurring in early life. In conclusion, during the PhD project, using a bench to bedside approach, several progresses in the field of diarrhea occurring in early life have been obtained. Epidemiology and etiology of diarrhea have been clarified, new therapeutic and preventive approaches have been developed for control of acute and chronic diarrhea occurring in early life. In addition, a novel model for the study of congenital diarrheal disease has been set. This model could be usefull to reduce the distance from in vitro to in vivo research on these rare conditions, and to identify new therapeutic targets for more common diarrheal disease occurring early in life. The main future target was the intestinal ecosystem (i.e., epithelium, immunity, microflora, nutrients), a dynamic network that could be modulated by different therapeutic and nutritional approaches. Epigenetic modulation of gene expression in early life elicited by nutrients, in order to modify the natural course of the disease, represents the new research frontier

    PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome

    No full text
    Previous work has shown that the protein kinase A (PKA)–regulated phosphodiesterase (PDE) 4D3 binds to A kinase–anchoring proteins (AKAPs). One such protein, AKAP9, localizes to the centrosome. In this paper, we investigate whether a PKA–PDE4D3–AKAP9 complex can generate spatial compartmentalization of cyclic adenosine monophosphate (cAMP) signaling at the centrosome. Real-time imaging of fluorescence resonance energy transfer reporters shows that centrosomal PDE4D3 modulated a dynamic microdomain within which cAMP concentration selectively changed over the cell cycle. AKAP9-anchored, centrosomal PKA showed a reduced activation threshold as a consequence of increased autophosphorylation of its regulatory subunit at S114. Finally, disruption of the centrosomal cAMP microdomain by local displacement of PDE4D3 impaired cell cycle progression as a result of accumulation of cells in prophase. Our findings describe a novel mechanism of PKA activity regulation that relies on binding to AKAPs and consequent modulation of the enzyme activation threshold rather than on overall changes in cAMP levels. Further, we provide for the first time direct evidence that control of cell cycle progression relies on unique regulation of centrosomal cAMP/PKA signals

    Investigation of chronic diarrhoea in infancy.

    No full text
    Diarrhoea in infants and young children is defined as >200g/day of stools, and occurs when there is an imbalance between intestinal fluids absorption and secretion. This may be caused by either a decreased absorption (osmotic diarrhoea) or an increased secretion (secretory diarrhoea). Chronic diarrhoea defines intestinal loss of water and electrolytes with increased stool frequency, reduced consistency and larger volume over more than 14days. This disorder in children shows a wide range of aetiologies depending on the age. The knowledge of common and rare aetiologies is important to optimize the diagnostic approach. A stepwise approach, starting with a comprehensive history, physical examination, inspection and collection of stool samples, helps to devise appropriate diagnostic and therapeutic management. In this article we discuss the pathophysiology, aetiology and possible approach to chronic diarrhoea in infancy
    corecore